ReviewActa oncologica (Stockholm, Sweden)2024

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST.

Loic Verlingue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.